MDT

95.75

-0.44%↓

VEEV

295.35

+2.17%↑

A

142.7

+2.53%↑

HQY

92.05

-3.24%↓

TLRY

1.63

0%↓

MDT

95.75

-0.44%↓

VEEV

295.35

+2.17%↑

A

142.7

+2.53%↑

HQY

92.05

-3.24%↓

TLRY

1.63

0%↓

MDT

95.75

-0.44%↓

VEEV

295.35

+2.17%↑

A

142.7

+2.53%↑

HQY

92.05

-3.24%↓

TLRY

1.63

0%↓

MDT

95.75

-0.44%↓

VEEV

295.35

+2.17%↑

A

142.7

+2.53%↑

HQY

92.05

-3.24%↓

TLRY

1.63

0%↓

MDT

95.75

-0.44%↓

VEEV

295.35

+2.17%↑

A

142.7

+2.53%↑

HQY

92.05

-3.24%↓

TLRY

1.63

0%↓

Search

Microbot Medical Inc

Abrir

2.95 -1.01

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.8

Máximo

3.01

Indicadores-chave

By Trading Economics

Rendimento

-899K

-3.5M

Margem de lucro

-4,038.095

Funcionários

20

EBITDA

-84K

-3.5M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+316.67% upside

Dividendos

By Dow Jones

Próximos Ganhos

12 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

31M

159M

Abertura anterior

3.96

Fecho anterior

2.95

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Microbot Medical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de out. de 2025, 23:25 UTC

Grandes Movimentos do Mercado

Salesforce Rises on New FY30 Financial Targets

15 de out. de 2025, 18:52 UTC

Ganhos
Grandes Movimentos do Mercado

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 de out. de 2025, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Software to Buy U.K.'s Tecvia Holding

15 de out. de 2025, 17:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 de out. de 2025, 17:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 de out. de 2025, 23:48 UTC

Conversa de Mercado

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 de out. de 2025, 23:38 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 de out. de 2025, 22:37 UTC

Conversa de Mercado

Economic Stars Are Aligning for RBA -- Market Talk

15 de out. de 2025, 21:44 UTC

Ganhos

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 de out. de 2025, 20:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

15 de out. de 2025, 20:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 de out. de 2025, 20:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 de out. de 2025, 20:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 de out. de 2025, 20:34 UTC

Ganhos

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 de out. de 2025, 20:31 UTC

Aquisições, Fusões, Aquisições de Empresas

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 de out. de 2025, 20:17 UTC

Aquisições, Fusões, Aquisições de Empresas

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 de out. de 2025, 19:06 UTC

Ganhos

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 de out. de 2025, 19:04 UTC

Conversa de Mercado

Oil Futures Post Back-to-Back Losses -- Market Talk

15 de out. de 2025, 18:46 UTC

Conversa de Mercado

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 de out. de 2025, 18:23 UTC

Ganhos

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 de out. de 2025, 17:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 de out. de 2025, 17:34 UTC

Conversa de Mercado

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 de out. de 2025, 16:57 UTC

Ganhos

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 de out. de 2025, 16:51 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica Doesn't Disclose Financial Details

15 de out. de 2025, 16:50 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 de out. de 2025, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 de out. de 2025, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 de out. de 2025, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 de out. de 2025, 16:47 UTC

Aquisições, Fusões, Aquisições de Empresas

EssilorLuxottica Buys Ikerian

15 de out. de 2025, 16:34 UTC

Conversa de Mercado

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Comparação entre Pares

Variação de preço

Microbot Medical Inc Previsão

Preço-alvo

By TipRanks

316.67% parte superior

Previsão para 12 meses

Média 12 USD  316.67%

Máximo 12 USD

Mínimo 12 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Microbot Medical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

1

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

2.52 / 2.57Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Very Strong Bullish Evidence

Longo Prazo

Weak Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat